Intellectual Property

This is the third part of our four-part series on the EUIPO study on GenAI and copyright. Read parts 1, 2, and 4.

This third part of the four-part series offers four key takeaways on GenAI output, highlighting critical issues around retrieval augmented generation (RAG), transparency solutions, copyright retention concerns and emerging technical

PatentNext Summary: In Brightex Bio-Photonics, LLC v. L’Oreal USA, Inc., the U.S. District Court for the Northern District of California invalidated patent claims relating to AI-driven cosmetic recommendations, finding them directed to an abstract idea under 35 U.S.C. § 101. The court held that while the specification referenced artificial intelligence, the claims themselves failed to